1. Refining BRCA1 and BRCA2 penetrance estimates in the clinic

   • Susan M. Domchek

   OriginalPaper 16 August 2009 Pages: 127 - 130

2. Genome-wide association studies identify new breast cancer susceptibility genes

   • Fergus J. Couch
   • Xianshu Wang

   OriginalPaper 16 August 2009 Pages: 131 - 138

3. Oral contraceptives and breast cancer risk in BRCA1 and BRCA2 mutation carriers

   • Jane C. Figueiredo
   • Robert W. Haile
   • Jonine L. Bernstein

   OriginalPaper 16 August 2009 Pages: 139 - 147

4. Statins may reduce breast cancer risk, particularly hormone receptor-negative disease

   • Shaveta Vinayak
   • Allison W. Kurian

   OriginalPaper 16 August 2009 Pages: 148 - 156

5. Prophylactic oophorectomy may differentially reduce breast cancer risk in women with BRCA1 versus BRCA2 mutations

   • Angela G. Arnold
   • Noah D. Kauff

   OriginalPaper 16 August 2009 Pages: 157 - 161

6. Increasing contralateral mastectomy use at diagnosis: Surgical prevention of contralateral breast cancer

   • Todd M. Tuttle
   • Amanda Arrington
   • Natasha Rueth

   OriginalPaper 16 August 2009 Pages: 162 - 166

7. Refining risk assessment in women with atypical hyperplasia

   • Amy C. Degnim
   • Lynn C. Hartmann

   OriginalPaper 16 August 2009 Pages: 167 - 174

8. Mammographic density as a marker of breast cancer risk?

   • Jeffrey A. Tice

   OriginalPaper 16 August 2009 Pages: 175 - 180